Neurocrine Biosciences Inc (NBIX)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 169,500 0 0 169,000 377,700 335,100 330,700 326,300 322,000 317,900 425,000 419,500 414,100 408,807 403,589 398,466 393,435
Total stockholders’ equity US$ in thousands 2,232,000 2,002,100 1,853,000 1,684,500 1,707,800 1,544,600 1,423,400 1,391,100 1,374,000 1,346,000 1,279,200 1,205,600 1,126,200 804,300 831,200 700,300 636,900 574,500 483,700 409,300
Debt-to-capital ratio 0.00 0.00 0.00 0.09 0.00 0.00 0.11 0.21 0.20 0.20 0.20 0.21 0.22 0.35 0.34 0.37 0.39 0.41 0.45 0.49

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $2,232,000K)
= 0.00

The debt-to-capital ratio for Neurocrine Biosciences, Inc. has been relatively stable over the past eight quarters, ranging from 0.07 to 0.21. A lower debt-to-capital ratio indicates that the company relies less on debt financing compared to its capital structure.

The decreasing trend from Q1 2022 to Q4 2023 suggests that the company has been gradually reducing its reliance on debt to finance its operations and investments. This can be seen as a positive sign as it indicates improved financial stability and lower financial risk.

It is important to consider that an extremely low debt-to-capital ratio might also indicate underutilization of debt as a cheaper source of financing. Conversely, a high debt-to-capital ratio can indicate high financial risk. Therefore, a moderate level of debt-to-capital ratio is generally considered healthy for a company's financial structure.

Overall, based on the trend observed in the debt-to-capital ratio over the past eight quarters, Neurocrine Biosciences, Inc. seems to be managing its debt levels effectively and maintaining a balanced capital structure.


Peer comparison

Dec 31, 2023